Evolva

Evolva and Breko broaden partnership by signing agreement for the exclusive distribution of Veri-teTM Resveratrol in Germany, Austria, Thailand and Vietnam

Retrieved on: 
Thursday, December 14, 2023
Resveratrol, Partnership, Food, Dietary supplement, News, Pharmaceutical industry, Evolva

The partners have already been working together for more than five years, resulting in compound annual revenue growth of more than 50%.

Key Points: 
  • The partners have already been working together for more than five years, resulting in compound annual revenue growth of more than 50%.
  • With this agreement on an exclusive basis, this very successful relationship is now being formalized.
  • The agreement broadens the already existing long-term partnership by granting exclusivity to Breko and covering additional markets.
  • Breko was already instrumental in obtaining approval for Veri-teTM Resveratrol from the Thai Food and Drug Administration earlier this year.

Evolva receives approval for Veri-teTM Resveratrol in Thailand

Retrieved on: 
Wednesday, September 6, 2023
Food, ASIA, HI, Functional food, Resveratrol, Dietary supplement, European cuisine, Evolva

Thailand will be the fifth country in South-East Asia after the Philippines, Malaysia, Vietnam and Taiwan where Veri-teTM Resveratrol is available for use in foods and dietary supplements.

Key Points: 
  • Thailand will be the fifth country in South-East Asia after the Philippines, Malaysia, Vietnam and Taiwan where Veri-teTM Resveratrol is available for use in foods and dietary supplements.
  • The approval was obtained with support of Breko and Brenntag Ingredients (Thailand) Public Company Limited.
  • Breko and Brenntag Ingredients (Thailand) Public Company Limited have been working together in Thailand for many years, bringing innovative ingredients from Europe to the region.
  • Anne De Vos, Chief Commercial Officer of Evolva, comments: ”Our Veri-teTM Resveratrol is a responsible multi-functional ingredient with proven health benefits supported by a number of clinical studies.

Evolva shareholders approve increase of the conditional capital and upper limit of capital band at extraordinary general meeting of 24 August 2023

Retrieved on: 
Thursday, August 24, 2023
Nice, Article, EGM, Sale, Trust, Articles of association, Extraordinary general meeting, Management, Security (finance), Evolva

Reinach, 24 August 2023 — The shareholders of Evolva Holding SA (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, approved the proposals put forward by the Board of Directors at today’s Extraordinary General Meeting.

Key Points: 
  • Reinach, 24 August 2023 — The shareholders of Evolva Holding SA (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, approved the proposals put forward by the Board of Directors at today’s Extraordinary General Meeting.
  • At today’s Extraordinary General Meeting (EGM) of Evolva Holding SA in Basel, the shareholders expressed their trust in the Board of Directors (Board) by approving, with large majorities (see details below), both proposals put forward by the Board: the increase of the conditional capital as well as the increase of the upper limit of the capital band.
  • Stephan Schindler, Chairman of Evolva, commented on the successful conclusion of the EGM: “We would like to thank our shareholders for their ongoing trust and support in these challenging times.
  • Increase of the upper limit of the capital band (Article 3b Articles of Association) to CHF 7‘836‘771.00 and respective amendment of Articles of Association: with 90.60% of the votes represented (votes represented: 2,002,673 of the total outstanding shares/votes of 5,224,514).

Evolva receives approval for Veri-teTM Resveratrol in Taiwan

Retrieved on: 
Tuesday, July 25, 2023
Partnership, Champion, Dietary supplement, Food, Resveratrol, Evolva

The approval is an important milestone as it opens up Taiwan as a further South-East Asian market after the Philippines, Malaysia and Vietnam where Veri-teTM Resveratrol is already available for use in foods and dietary supplements.

Key Points: 
  • The approval is an important milestone as it opens up Taiwan as a further South-East Asian market after the Philippines, Malaysia and Vietnam where Veri-teTM Resveratrol is already available for use in foods and dietary supplements.
  • The approval was obtained in close partnership with Champion Co. Ltd., Evolva’s Taiwanese distribution partner, who supported Evolva throughout the registration process.
  • Anne De Vos, Chief Commercial Officer of Evolva, comments: ”Our Veri-teTM Resveratrol, is a multi-functional ingredient with proven health benefits.
  • Veri-teTM Resveratrol is a main pillar of Evolva’s Health Ingredients business and a key focus area to boost our commercial performance.”

Evolva publishes timeline of the Reverse Stock Split

Retrieved on: 
Monday, April 24, 2023
Annual general meeting, Annual, Pharmaceutical industry, Security (finance), Evolva

Reinach, 24 April 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, today communicates on the timeline of the reverse stock split of 250:1 which was approved by shareholders at the Annual General Meeting on 18 April 2023 by a large majority:

Key Points: 
  • Reinach, 24 April 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, today communicates on the timeline of the reverse stock split of 250:1 which was approved by shareholders at the Annual General Meeting on 18 April 2023 by a large majority:
    The reverse split of shares may result in fractions of new registered shares for the individual shareholder.
  • This is the case if shareholders hold an amount of Evolva shares that is not divisible by 250 or a multiple thereof after the 25 April 2023.
  • Fractions in new shares are rounded down to the next whole number and shareholders will receive an equivalent cash compensation for their fractions.

Evolva shareholders approve all motions proposed by the Board at today’s Annual General Meeting

Retrieved on: 
Tuesday, April 18, 2023
Executive, Compensation, Execution management system, Annual, AGM, Article, Management, Senior, Growth, Consolidated, Professional Football Compensation Committee, CHF, Articles of association, Reverse, Proxy, Holding company, Security (finance), Financial adviser, Evolva

Shareholders approved all proposals put forward by the Board of Directors by a large majority.

Key Points: 
  • Shareholders approved all proposals put forward by the Board of Directors by a large majority.
  • Discharge from liability of the members of the Board of Directors and the Executive Management for the fiscal year 2022.
  • Reverse stock split: the consolidation of the Evolva shares with a reverse split ratio of 250:1.
  • Furthermore, shareholders approved the ordinary capital increase for fractional compensation of CHF 11.45 as needed for the implementation of the reverse stock split.

Evolva goes Responsible Care at in-cosmetics 2023

Retrieved on: 
Tuesday, March 28, 2023
Hair, Senior, Research, Science, Oxidative stress, System, Human, News, Skin, Fine chemical, Cosmetics, Management, Evolva, Resveratrol

Evolva is globally launching an exclusive line of nature-based high-purity ingredients and bio-functionals for the personal care industry, produced in a sustainable manner

Key Points: 
  • Evolva is globally launching an exclusive line of nature-based high-purity ingredients and bio-functionals for the personal care industry, produced in a sustainable manner
    Reinach, 28 March 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, will launch its “Responsible Care” program for the personal care industry at the trade fair in-cosmetics in Barcelona, Spain, on 28-30 March 2023.
  • Specifically, Evolva at in-cosmetics will be featuring an exclusive line of two responsible ingredients and their powerful science: JUNEO and LARALLY.
  • Evolva has created a number of responsible product concepts for the event and will promote them under the headline: Think customagic!
  • Anne De Vos, Chief Commercial Officer of Evolva, comments:” We are very excited about the launch of our line of responsible active ingredients for the personal care industry.

Grace Breeding and Evolva Holdings Partner to Develop Next-Generation, Sustainable Crop Yield and Resilience Solutions

Retrieved on: 
Monday, March 6, 2023
Soil, TASE, CO2, Farmer, NFT, Health, Partnership, Evolva, Climate, Fertilizer

As a result, sustainable alternatives that also are competitive for crop health are in demand by farmers and distributors.

Key Points: 
  • As a result, sustainable alternatives that also are competitive for crop health are in demand by farmers and distributors.
  • Grace Breeding’s NFT bio-fertilizer is more environmentally friendly and cost-effective and also more potent to improve crop yield and resilience.
  • Grace Breeding’s NFT works in combination with a natural, non-pathogenic bacteria enabling crops to naturally fix nitrogen and reducing the need for chemical fertilizers.
  • Christian Wichert, Chief Executive Officer of Evolva Holding AG, added, “The partnership with Grace Breeding opens a new and attractive market for Evolva.

Evolva launches its Natural Nootkatone

Retrieved on: 
Sunday, December 18, 2022
Bell Flavors & Fragrances, Woman, Health, Nature, Aroma compound, Taste, Drink, Skin, Flavor, Smell, Fruit, Plant, Research, Citrus, Renewable energy, Perfume, Nootkatone, Evolva, EU

Reinach, 14 December 2022 – Evolva (SIX: EVE) a pioneer in the field of natural molecules and industrial biotech, is lauching “Natural Nootkatone by Evolva”, a natural ingredient at the highest purity level now meeting all requirements to be qualified as natural also in the EU, in addition to the US.

Key Points: 
  • Reinach, 14 December 2022 – Evolva (SIX: EVE) a pioneer in the field of natural molecules and industrial biotech, is lauching “Natural Nootkatone by Evolva”, a natural ingredient at the highest purity level now meeting all requirements to be qualified as natural also in the EU, in addition to the US.
  • By further refining the production process, Natural Nootkatone by Evolva is now meeting all requirements to be qualified as natural also in the EU, in addition to the US.
  • Anne De Vos, Chief Commercial Officer of Evolva, comments: ”The launch of our new Natural Nootkatone capitalizes on a clear market demand.
  • At the highest purity levels  Natural Nootkatone by Evolva comes in liquid (Natural Nootkatone 85%) and crystal forms (Natural Nootkatone 98%) and is fully approved for use in both flavors and fragrances.

Evolva statement to SER communication

Retrieved on: 
Sunday, December 18, 2022
Woman, Health, Evolva, Nature, Internal, P&L, SER, SIX Group, Research, CHF, Risk management

The respective decision was communicated today by SER.

Key Points: 
  • The respective decision was communicated today by SER.
  • The addressed deficiencies concern incomplete disclosures and technical mistakes related to the goodwill impairment tests in the financial reporting 2019 and 2020.
  • As already communicated on 23 August 2022, Evolva submitted a statement to the Sanctions Commission, which was aligned with the former and the current auditors in addition to being backed up with external advice.
  • The new management team, which joined Evolva in 2021 and 2022, has cooperated closely with SER and is committed to transparency towards all stakeholders.